GSTM2: Potential Drug Target Or Biomarker (G442245)

Target Name: GSTM2P1

NCBI ID: G442245

GSTM2P1

Other Name(s): Glutathione S-transferase mu 2 pseudogene 1 | glutathione S-transferase mu 2 pseudogene 1

GSTM2: Potential Drug Target Or Biomarker

GSTM2P1 is a gene that encodes for a protein known as glutathione S-transferase mu 2 (GSTM2) pseudogene 1. GSTM2 is a member of the GST family of transmembrane proteins that play a critical role in the detoxification and neutralization of toxic substances. Mutations in the GSTM2 gene have been linked to a variety of diseases, including drug addiction, autoimmune disorders, and neurodegenerative diseases.

While the exact function of GSTM2 is not yet fully understood, it is known to be involved in the detoxification of drugs and other harmful substances. This protein is expressed in many different tissues and cells in the body, including the liver, lung, and brain. It is also highly expressed in the placenta, which suggests that it may be involved in the transfer of harmful substances from the mother to the child.

One of the unique features of GSTM2 is its ability to transfer itself to other cells via a process called exon chain transfer. This allows the protein to be expressed in other tissues and cells, making it a potential drug target or biomarker.

GSTM2 has also been shown to play a role in the development and progression of certain neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have suggested that GSTM2 may be involved in the production of neurotoxins, which are substances that cause damage to the brain and contribute to the development of these diseases.

In addition to its potential role in neurodegenerative diseases, GSTM2 has also been shown to be involved in drug addiction. Studies have suggested that individuals with drug addiction may have increased levels of GSTM2 in their brains, which may contribute to the development and maintenance of addiction.

While more research is needed to fully understand the role of GSTM2 in these diseases, its potential as a drug target or biomarker is an exciting area of study. If GSTM2 is indeed involved in the detoxification and neutralization of toxic substances, it may be potential target for drugs that are used to treat addiction and other neurodegenerative diseases.

In conclusion, GSTM2P1 is a gene that encodes for a protein that is involved in the detoxification and neutralization of toxic substances. Its unique ability to transfer itself to other cells via exon chain transfer makes it a potential drug target or biomarker, and its involvement in the development and progression of certain neurodegenerative diseases and drug addiction suggests that it may have important roles to play in the future of medicine. Further research is needed to fully understand the function of GSTM2 and its potential as a drug target or biomarker.

Protein Name: Glutathione S-transferase Mu 2 Pseudogene 1

The "GSTM2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GSTM2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets